Biogen has named Spyros Artavanis-Tsakonas, Ph.D., the company’s Chief Scientific Officer. Dr. Artavanis-Tsakonas had served as interim CSO while on sabbatical from Harvard Medical School. He will now continue in this role in a permanent capacity, and will also lead the company’s research strategy, capabilities and discovery platforms.
- Health Care Industry
- Investment & Company Information
- Harvard Medical School